Scale-backs and deep spending cuts within the US government and the Global Fund to Fight AIDS are hobbling HIV treatment programs across Africa, including in Ethiopia, warns a new report from a UN ...

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

Researchers at Case Western Reserve University have made a significant breakthrough in HIV treatment. They’ve shown that NK ...

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

Today, that fight continues as Indiana confronts the urgent need to reform its HIV criminal laws and remove stigma from our ...

People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral self-test.

With Black Americans disproportionately affected by HIV, it's a day to encourage testing, prevention, and treatment but also to talk about systemic barriers.

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

So far, there is no "magic bullet" to cure HIV for good, but scientists are making rapid progress.